{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:11Z","timestamp":1792784111688,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["30971015"],"award-info":[{"award-number":["30971015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Harbin Science and Technology Innovation Talents of Special Fund Project","award":["2009RFXXS021"],"award-info":[{"award-number":["2009RFXXS021"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jneuroim.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T09:17:52Z","timestamp":1360833472000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23\/IL-17-mediated ischemic stroke in mice"],"prefix":"10.1016","volume":"257","author":[{"given":"Shuainan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2008","key":"10.1016\/j.jneuroim.2013.01.007_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","article-title":"Th17 cells and autoimmune encephalomyelitis (EAE\/MS)","volume":"57","author":"Aranami","year":"2008","journal-title":"Allergol. Int."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00004647-199908000-00001","article-title":"Inflammatory mediators and stroke: new opportunities for novel therapeutics","volume":"19","author":"Barone","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainres.2004.02.050","article-title":"Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier","volume":"1009","author":"Borlongan","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/scrt34","article-title":"New concepts on the immune modulation mediated by mesenchymal stem cells","volume":"1","author":"Bunnell","year":"2010","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ten.teb.2008.0515","article-title":"New era of cell-based orthopedic therapies","volume":"15","author":"Caplan","year":"2009","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004647-199603000-00002","article-title":"Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis","volume":"16","author":"Charriaut-Marlangue","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","article-title":"Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0040","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI25308","article-title":"Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis","volume":"116","author":"Chen","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0045","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0050","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0055","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"Stroke","volume":"371","author":"Donnan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0060","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00004647-199810000-00003","article-title":"Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation","volume":"18","author":"Fink","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.autrev.2006.10.002","article-title":"Autoimmune inflammation from the Th17 perspective","volume":"6","author":"Furuzawa-Carballeda","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"2011","key":"10.1016\/j.jneuroim.2013.01.007_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of Interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0075","first-page":"1440","article-title":"Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct","author":"Kawabori","year":"2012","journal-title":"Neuropathology"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0080","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH 17 lymphocytes promote blood\u2013brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0090","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.200838729","article-title":"BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO","volume":"39","author":"Kong","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0095","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnen\/63.9.942","article-title":"A role for interferon-gamma in focal cerebral ischemia in mice","volume":"63","author":"Lambertsen","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.2005.01683.x","article-title":"Expression of interleukin-17 in ischemic brain tissue","volume":"62","author":"Li","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00004647-200206000-00010","article-title":"Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion","volume":"22","author":"Matsui","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"Meirelles Lda","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb9000","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and Type 17 Helper T Cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2009","key":"10.1016\/j.jneuroim.2013.01.007_bb0120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/mt.2009.62","article-title":"Repair of tissues by adult stem\/progenitor cells (MSCs): controversies, myths, and changing paradigms","volume":"17","author":"Prockop","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(07)60155-X","article-title":"Experimental treatments for acute ischaemic stroke","volume":"369","author":"Sacco","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cyto.2005.02.012","article-title":"IL-17 reduces TNF-induced Rantes and VCAM-1 expression","volume":"31","author":"Schnyder","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0140","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nm.1999","article-title":"Pivotal role of cerebral interleukin-17-producing\u03b3\u03b4-T cells in the delayed phase of ischemic brain injury","volume":"15","author":"Shichita","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0145","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nbd.2012.03.002","article-title":"Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats","volume":"46","author":"Wei","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/scd.2009.0076","article-title":"The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity","volume":"19","author":"Xue","year":"2010","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jneuroim.2013.01.007_bb0155","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.105.593046","article-title":"Role of T lymphocytes and interferon-gamma in ischemic stroke","volume":"113","author":"Yilmaz","year":"2006","journal-title":"Circulation"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:45Z","timestamp":1759047585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0165572813000210"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23\/IL-17-mediated ischemic stroke in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}